Scancell’s iSCIB1+ shows 74% PFS in melanoma trial
Proactive - Interviews for investors · Proactive Investors
December 10, 20254m 48s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.